On November 18, 2021, a mitral valve seal surgery using MitraClip (without opening the chest) and CarnaLife Holo took place. The procedure was performed at the University Clinical Hospital in Opole, by a team led by dr. hab. n. med. Jerzy Sacha.
Three-dimensional visualization of imaging diagnostic data of the heart was used in planning and throughout the procedure. As the sterility of the room was not compromised, physicians were able to use the CarnaLife Holo technology unobstructed throughout the procedure and observe the injection sites closely.
“With the unique CarnaLife Holo technology, developed by the Polish company MedApp, we obtained holographic images of the inside of the heart, which were used during the MitraClip valve repair procedure without opening the chest,” explains cardiologist dr. hab. med. Jerzy Sacha and adds: “I can say that the technology of 3D visualization of diagnostic data is the future. We should all give it a try and invest in holography experience.
The surgery was conducted by a team consisting of:
dr hab. n. med. Jerzy Sacha
Dr Krzysztof Krawczyk (cardiologist)
Dr Jaroslaw Bugajski (cardiologist)
Mateusz Stanisz (anesthesiologist)
Monika Świderska (assistant)
Małgorzata Werner (assistant)
Danuta Radiszewska (anesthesiology nurse)
Filip Zuczek (x-ray technician).
Technological assistance was provided by Jakub Kasprzak and Kacper Pabianek from MedApp, Tomasz Ogonowski from GE and Szymon Dziedzic (Abbott).
Read more See similar articles:
CarnaLife Holo with FDA (Food and Drugs Administration) certification for the US market!
We are proud to announce that our CarnaLile Holo technology for augmented reality imaging of medical data (interactive holograms) has received 510(k) Class II certification for the world’s largest and richest market for new technology and robotic technology.
MedApp after Q4 2022: continued development of digital medicine technology solutions and acquisition of new sales contacts
As in the previous quarters of 2022, the Company is observing an extension of sales processes in the Polish market, trying to shift sales activity to foreign markets. To this end, the Company has signed further distribution agreements for the CarnaLife Holo solution
We are looking for companies and individuals interested in distributing MedApp’s medical technology.
CarnaLife Holo is a breakthrough technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. With the help of Microsoft’s HoloLens 2, the physician can see in real space a three-dimensional hologram reflecting the structure of the imaged anatomical area.